Viridian Therapeutics, Inc. earnings per share and revenue

VRDN earnings per share for the last quarter are -0.79 USD whereas the estimation was -1.09 USD which accounts for 27.46% surprise. Företagets omsättning för samma period uppgår till 72.00 k USD trots den uppskattade siffran 88.10 k USD. Estimated earnings per share for the next quarter are -0.88 USD, and revenue is expected to reach 95.42 k USD. Also watch annual changes over time to get a bigger picture of VRDN earnings per share and revenue dynamics.